These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 18635359)
1. Necrotic cell death and 'necrostatins': now we can control cellular explosion. Vandenabeele P; Declercq W; Vanden Berghe T Trends Biochem Sci; 2008 Aug; 33(8):352-5. PubMed ID: 18635359 [TBL] [Abstract][Full Text] [Related]
4. Structural basis of RIP1 inhibition by necrostatins. Xie T; Peng W; Liu Y; Yan C; Maki J; Degterev A; Yuan J; Shi Y Structure; 2013 Mar; 21(3):493-9. PubMed ID: 23473668 [TBL] [Abstract][Full Text] [Related]
5. Programmed cell death with a necrotic-like phenotype. Morgan MJ; Liu ZG Biomol Concepts; 2013 Jun; 4(3):259-75. PubMed ID: 25436579 [TBL] [Abstract][Full Text] [Related]
6. Ripoptosome: a novel IAP-regulated cell death-signalling platform. Imre G; Larisch S; Rajalingam K J Mol Cell Biol; 2011 Dec; 3(6):324-6. PubMed ID: 22114055 [TBL] [Abstract][Full Text] [Related]
7. Activity assays for receptor-interacting protein kinase 1:a key regulator of necroptosis. Maki JL; Degterev A Methods Mol Biol; 2013; 1004():31-42. PubMed ID: 23733567 [TBL] [Abstract][Full Text] [Related]
9. Induction of tumor cell apoptosis or necrosis by conditional expression of cell death proteins: analysis of cell death pathways and in vitro immune stimulatory potential. Lohmann C; Muschaweckh A; Kirschnek S; Jennen L; Wagner H; Häcker G J Immunol; 2009 Apr; 182(8):4538-46. PubMed ID: 19342627 [TBL] [Abstract][Full Text] [Related]
10. Attenuation of cadmium-induced necrotic cell death by necrostatin-1: potential necrostatin-1 acting sites. Hsu TS; Yang PM; Tsai JS; Lin LY Toxicol Appl Pharmacol; 2009 Mar; 235(2):153-62. PubMed ID: 19135076 [TBL] [Abstract][Full Text] [Related]
11. Expression and purification of active receptor interacting protein 1 kinase using a baculovirus system. Maki JL; Tres Brazell J; Teng X; Cuny GD; Degterev A Protein Expr Purif; 2013 Jun; 89(2):156-61. PubMed ID: 23523699 [TBL] [Abstract][Full Text] [Related]
13. Immunogenic cell death modalities and their impact on cancer treatment. Kepp O; Tesniere A; Schlemmer F; Michaud M; Senovilla L; Zitvogel L; Kroemer G Apoptosis; 2009 Apr; 14(4):364-75. PubMed ID: 19145485 [TBL] [Abstract][Full Text] [Related]
14. Identification of RIP1 kinase as a specific cellular target of necrostatins. Degterev A; Hitomi J; Germscheid M; Ch'en IL; Korkina O; Teng X; Abbott D; Cuny GD; Yuan C; Wagner G; Hedrick SM; Gerber SA; Lugovskoy A; Yuan J Nat Chem Biol; 2008 May; 4(5):313-21. PubMed ID: 18408713 [TBL] [Abstract][Full Text] [Related]
15. RIP1 comes back to life as a cell death regulator in TNFR1 signaling. O'Donnell MA; Ting AT FEBS J; 2011 Apr; 278(6):877-87. PubMed ID: 21232018 [TBL] [Abstract][Full Text] [Related]
17. The molecular regulation of programmed necrotic cell injury. Moquin D; Chan FK Trends Biochem Sci; 2010 Aug; 35(8):434-41. PubMed ID: 20346680 [TBL] [Abstract][Full Text] [Related]
18. Bromocriptine induces parapoptosis as the main type of cell death responsible for experimental pituitary tumor shrinkage. Palmeri CM; Petiti JP; Sosa Ldel V; Gutiérrez S; De Paul AL; Mukdsi JH; Torres AI Toxicol Appl Pharmacol; 2009 Oct; 240(1):55-65. PubMed ID: 19595700 [TBL] [Abstract][Full Text] [Related]
19. Nutritional lipid-induced oxidative stress leads to mitochondrial dysfunction followed by necrotic death in FaO hepatocytes. Tirosh O; Ilan E; Anavi S; Ramadori G; Madar Z Nutrition; 2009 Feb; 25(2):200-8. PubMed ID: 18947977 [TBL] [Abstract][Full Text] [Related]
20. Activation of p38 mitogen-activated protein kinase is required for death receptor-independent caspase-8 activation and cell death in response to sphingosine. Yoon CH; Kim MJ; Park MT; Byun JY; Choi YH; Yoo HS; Lee YM; Hyun JW; Lee SJ Mol Cancer Res; 2009 Mar; 7(3):361-70. PubMed ID: 19276187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]